Besides common EGFR mutations, uncommon EGFR mutations are described, of which molecular diagnosis is facilitated by new molecular techniques, such as next-generation sequencing (NGS) or multiplex polymerase chain reaction (PCR), in FFPE tumor samples as well as in liquid biopsy, which is easy to practice and able to detect EGFR mutations in plasma. Here, EGFR is linked to neoplasm.